Jurkat 76 BioVector?人類T淋巴細(xì)胞缺陷型細(xì)胞系 / Jurkat 76 Human T-Lymphocyte Deficient Cell Line
- 價(jià) 格:¥998950
- 貨 號(hào):BioVector? Jurkat 76
- 產(chǎn) 地:北京
- BioVector NTCC典型培養(yǎng)物保藏中心
- 聯(lián)系人:Dr.Xu, Biovector NTCC Inc.
電話:400-800-2947 工作微信:1843439339 (QQ同號(hào))
手機(jī):18901268599
地址:北京
- 已注冊(cè)
BioVector? Jurkat 76 人類 T 淋巴細(xì)胞缺陷型細(xì)胞系 / Jurkat 76 Human T-Lymphocyte Deficient Cell Line
通用定義 / General Definition:
BioVector? Jurkat 76 是經(jīng)典 Jurkat 細(xì)胞系的一個(gè)特殊衍生亞型。該細(xì)胞系的獨(dú)特之處在于它是 $TCR$(T 細(xì)胞受體)和 $CD3$ 表達(dá)缺陷型。由于它不表達(dá)內(nèi)源性 $TCR$$\alpha$ 和 $\beta$ 鏈,因此不會(huì)產(chǎn)生內(nèi)源性 TCR 復(fù)合物的干擾。這使得 Jurkat 76 成為 TCR 基因轉(zhuǎn)導(dǎo)、TCR 結(jié)構(gòu)與功能研究、以及新型 TCR-T 免疫療法篩選的理想“空白受體”模型。
BioVector? Jurkat 76 is a specialized derivative of the classic Jurkat cell line. Its defining characteristic is the lack of endogenous $TCR$ (T-cell receptor) and $CD3$ expression. Because it does not produce endogenous TCR $\alpha$ and $\beta$ chains, there is no interference from native TCR complexes. This makes Jurkat 76 an ideal "blank slate" model for TCR gene transduction, studies on TCR structure and function, and the screening of novel TCR-T immunotherapies.
BioVector? Jurkat 76 細(xì)胞系技術(shù)說(shuō)明書(shū) (Cell Line Datasheet)
中文版說(shuō)明書(shū)
1. 產(chǎn)品基本信息
產(chǎn)品名稱: BioVector? Jurkat 76 人 T 淋巴細(xì)胞缺陷型細(xì)胞
細(xì)胞來(lái)源: 人類 (Human)
組織來(lái)源: 外周血 (Peripheral Blood / T-cell Leukemia)
生長(zhǎng)特性: 懸浮生長(zhǎng) (Suspension)
細(xì)胞形態(tài): 淋巴母細(xì)胞樣
2. 培養(yǎng)條件
基礎(chǔ)培養(yǎng)基: BioVector? RPMI 1640 培養(yǎng)基
血清添加: 10% BioVector? 胎牛血清 (FBS)
培養(yǎng)環(huán)境: 37°C,5% $CO_2$
3. 細(xì)胞應(yīng)用
TCR 重組研究: 轉(zhuǎn)染外源性 TCR 基因以研究特定的抗原識(shí)別。
抗原提呈驗(yàn)證: 與表達(dá)特定 pMHC 的靶細(xì)胞共培養(yǎng),檢測(cè)激活信號(hào)。
信號(hào)轉(zhuǎn)導(dǎo)機(jī)制: 研究 TCR 缺失背景下,其他共刺激分子或細(xì)胞因子受體的功能。
4. 注意事項(xiàng)
細(xì)胞密度: 建議維持密度在 $1 \times 10^5$ 至 $1 \times 10^6$ cells/mL 之間。懸浮細(xì)胞對(duì)營(yíng)養(yǎng)消耗較快,需定期觀察。
缺陷驗(yàn)證: 在進(jìn)行 TCR 轉(zhuǎn)染實(shí)驗(yàn)前,建議通過(guò)流式細(xì)胞術(shù) (FACS) 再次確認(rèn) CD3/TCR 的陰性背景。
English Datasheet
1. General Product Information
Product Name: BioVector? Jurkat 76 Human T-Lymphocyte Deficient Cell Line
Organism: Human
Tissue Source: Peripheral Blood (T-cell Leukemia)
Growth Properties: Suspension
Morphology: Lymphoblast-like
2. Culture Conditions
Basal Medium: BioVector? RPMI 1640 Medium
Serum Supplement: 10% BioVector? Fetal Bovine Serum (FBS)
Incubation: 37°C, 5% $CO_2$
3. Applications
TCR Reconstitution: Transfecting exogenous TCR genes to study specific antigen recognition without endogenous competition.
Antigen Presentation Assays: Co-culturing with pMHC-expressing target cells to monitor downstream activation signals (e.g., IL-2 production).
Signaling Research: Investigating the role of co-stimulatory molecules or cytokine receptors in a TCR-negative background.
4. Key Usage Notes
Maintenance Density: Keep cell concentration between $1 \times 10^5$ and $1 \times 10^6$ cells/mL. Suspension cultures exhaust nutrients quickly and require regular monitoring.
Phenotypic Confirmation: It is highly recommended to verify the CD3/TCR negative status via Flow Cytometry (FACS) prior to beginning any TCR reconstitution experiments to ensure the BioVector? Jurkat 76 "blank" background.
Note: Handle BioVector? Jurkat 76 cells under Biosafety Level 2 (BSL-2) standards. For optimal transfection efficiency of large TCR constructs, the use of BioVector? RPMI 1640 Medium and high-grade BioVector? Fetal Bovine Serum is essential.


Supplier生產(chǎn)廠家: BioVector NTCC典型培養(yǎng)物保藏中心
E-mail: [email protected]
http://www.nedfriskphoto.com
您正在向 biovector.net 發(fā)送關(guān)于產(chǎn)品 Jurkat 76 BioVector?人類T淋巴細(xì)胞缺陷型細(xì)胞系 / Jurkat 76 Human T-Lymphocyte Deficient Cell Line 的詢問(wèn)
- 公告/新聞




